| Left | |
|---|---|
| C50.012 | Malignant neoplasm of nipple and areola, left female breast |
| C50.212 | Malignant neoplasm of upper-inner quadrant, left female breast |
| C50.312 | Malignant neoplasm of lower-inner quadrant, left female breast |
| C50.412 | Malignant neoplasm of upper-outer quadrant, left female breast |
Primary malignant neoplasm of left upper inner quadrant of female breast ICD-10-CM C50.212 is grouped within Diagnostic Related Group (s) (MS-DRG v38.0): 582 Mastectomy for malignancy with cc/mcc 583 Mastectomy for malignancy without cc/mcc
Sarcoma of bilateral female breasts Sarcoma of left female breast ICD-10-CM C50.912 is grouped within Diagnostic Related Group (s) (MS-DRG v38.0): 582 Mastectomy for malignancy with cc/mcc
Unspecified lump in the left breast, upper inner quadrant. N63.22 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM N63.22 became effective on October 1, 2018.
2016 2017 2018 2019 Billable/Specific Code Female Dx. C50.912 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2018/2019 edition of ICD-10-CM C50.912 became effective on October 1, 2018.
Malignant neoplasm of unspecified site of unspecified female breast. C50. 919 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C50.
ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10-CM Code for Intraductal carcinoma in situ of left breast D05. 12.
ICD-10 code C50. 912 for Malignant neoplasm of unspecified site of left female breast is a medical classification as listed by WHO under the range - Malignant neoplasms .
ICD-10 code: C90. 00 Multiple myeloma Without mention of complete remission.
96413. Chemotherapy administration, intravenous infusion technique, up to 1 hour, single or initial substance drug.
In the diagram below, the nipple is in the center of the clock for both breasts. The outer left breast is at 3 o'clock and the outer right breast is at 9 o'clock. In the left breast the upper outer quadrant is between 12 and 3 o'clock.
Breast Cancer ICD-10 Code Reference SheetLeftC50.012Malignant neoplasm of nipple and areola, left female breastC50.312Malignant neoplasm of lower-inner quadrant, left female breastC50.412Malignant neoplasm of upper-outer quadrant, left female breastC50.512Malignant neoplasm of lower-outer quadrant, left female breast8 more rows
3: Family history of malignant neoplasm of breast.
A form of breast cancer in which the tumor grows from ducts beneath the nipple onto the surface of the nipple. Symptoms commonly include itching and burning and an eczema-like condition around the nipple, sometimes accompanied by oozing or bleeding.
A malignant neoplasm in which there is infiltration of the skin overlying the breast by neoplastic large cells with abundant pale cytoplasm and large nuclei with prominent nucleoli (paget cells). It is almost always associated with an intraductal or invasive ductal carcinoma of the breast.
A malignant neoplasm (NEE-oh-plaz-um) is another term for a cancerous tumor. The term “neoplasm” refers to an abnormal growth of tissue. The term “malignant” means the tumor is cancerous and is likely to spread (metastasize) beyond its point of origin.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
Functional activity. All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology]
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
The 2022 edition of ICD-10-CM C50.912 became effective on October 1, 2021.
For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. Malignant neoplasm of ectopic tissue. Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, ...